Majdi N Al-Hasan

TitleCLINICAL PROFESSOR-USC
InstitutionUniversity of South Carolina School of Medicine
DepartmentMDC INTERNAL MEDICINE
Address5 MEDICAL PARK
Columbia, South Carolina 29203
Phone(803)540-1000
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Amipara R, Winders HR, Justo JA, Bookstaver PB, Kohn J, Al-Hasan MN. Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection. EClinicalMedicine. 2021 Apr; 34:100811. PMID: 33870154.
      Citations:    
    2. Shealy S, Kohn J, Yongue E, Troficanto C, Bookstaver PB, Justo JA, Winders HR, Dash S, Al-Hasan MN. Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System. Pharmacy (Basel). 2021 Feb 07; 9(1). PMID: 33562268.
      Citations:    
    3. Winders HR, Al-Hasan MN, Jones BM, Childress DT, Stover KR, Britt BB, Chahine EB, Lau S, Andrews PD, Junco SJ, Wrenn RH, Crane BJ, Wong JR, Seddon MM, Bland CM, MacVane SH, Gibson GM, Bookstaver PB. Novel method of calculating adjusted antibiotic use by microbiological burden. Infect Control Hosp Epidemiol. 2021 Jan 28; 1-6. PMID: 33504376.
      Citations:    
    4. Vo VD, Khalil MK, Al-Hasan MN. Risk and clinical outcomes of acute myocardial infarction and acute ischemic stroke following gram-negative bloodstream infection. Int J Cardiol Hypertens. 2021 Mar; 8:100079. PMID: 33598654.
      Citations:    
    5. Al-Hasan MN. Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy. Antibiotics (Basel). 2020 Dec 18; 9(12). PMID: 33352973.
      Citations:    
    6. Younas M, Royer J, Weissman SB, Winders HR, Dash S, Bookstaver PB, Justo JA, Waites KS, Bell L, Al-Hasan MN. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 May; 42(5):622-624. PMID: 33239121.
      Citations:    
    7. O'Neal M, Murray H, Dash S, Al-Hasan MN, Justo JA, Bookstaver PB. Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system. Ther Adv Infect Dis. 2020 Jan-Dec; 7:2049936120959561. PMID: 33014363.
      Citations:    
    8. Al-Hasan MN, Al-Jaghbeer MJ. Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients? Drugs Aging. 2020 09; 37(9):627-633. PMID: 32691330.
      Citations:    
    9. Plante JG, Winders HR, Bookstaver PB, Al-Hasan MN, Justo JA, Waites KS, Weissman S. Regional and statewide antibiograms as targeted interventions against antibiotic resistance. Infect Control Hosp Epidemiol. 2021 Apr; 42(4):503-505. PMID: 32583760.
      Citations:    
    10. Winders HR, Royer J, Younas M, Justo JA, Bookstaver PB, Weissman SB, Bell L, Waites KS, Plante J, Al-Hasan MN. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882. PMID: 32498729.
      Citations:    
    11. Derrick C, Bookstaver PB, Lu ZK, Bland CM, King ST, Stover KR, Rumley K, MacVane SH, Swindler J, Kincaid S, Branan T, Cluck D, Britt B, Pillinger KE, Jones BM, Fleming V, DiMondi VP, Estrada S, Crane B, Odle B, Al-Hasan MN, Justo JA. Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species. Antibiotics (Basel). 2020 May 14; 9(5). PMID: 32423104.
      Citations:    
    12. Shealy SC, Alexander C, Hardison TG, Magagnoli J, Justo JA, Derrick C, Kohn J, Winders HR, Privette T, Al-Hasan MN, Bookstaver PB. Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department. Pharmacy (Basel). 2020 Apr 23; 8(2). PMID: 32340149.
      Citations:    
    13. Shealy SC, Brigmon MM, Justo JA, Bookstaver PB, Kohn J, Al-Hasan MN. Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates. Antibiotics (Basel). 2020 Apr 17; 9(4). PMID: 32316502.
      Citations:    
    14. Al-Hasan MN, Baddour LM. Resilience of the Pitt Bacteremia Score: 3 Decades and Counting. Clin Infect Dis. 2020 04 15; 70(9):1834-1836. PMID: 31219546.
      Citations:    
    15. Al-Hasan MN. Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Moving Target. Clin Infect Dis. 2020 Apr 03. PMID: 32249916.
      Citations:    
    16. Al-Hasan MN, Gould AP, Drennan C, Hill O, Justo JA, Kohn J, Bookstaver PB. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93. PMID: 31887412.
      Citations:    
    17. Al-Hasan MN, Baddour LM. Erratum. Clin Infect Dis. 2019 11 27; 69(12):2238. PMID: 31639185.
      Citations:    
    18. DeMarsh M, Bookstaver PB, Gordon C, Lim J, Griffith N, Bookstaver NK, Justo JA, Kohn J, Al-Hasan MN. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222. PMID: 31683038.
      Citations:    
    19. Younas M, Royer J, Weissman SB, Waites KS, Dash S, Rac H, Bookstaver PB, Justo JA, Bell L, Maki A, Al-Hasan MN. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study. Infection. 2020 Feb; 48(1):129-132. PMID: 31677084.
      Citations:    
    20. Al-Hasan MN, Winders HR, Bookstaver PB, Justo JA. Direct Measurement of Performance: A New Era in Antimicrobial Stewardship. Antibiotics (Basel). 2019 Aug 24; 8(3). PMID: 31450576.
      Citations:    
    21. Seddon MM, Bookstaver PB, Justo JA, Kohn J, Rac H, Haggard E, Mediwala KN, Dash S, Al-Hasan MN. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420. PMID: 30312362.
      Citations:    
    22. Brett AS, Al-Hasan MN. COPD Exacerbations - A Target for Antibiotic Stewardship. N Engl J Med. 2019 07 11; 381(2):174-175. PMID: 31291521.
      Citations:    
    23. Mediwala KN, Kohn JE, Bookstaver PB, Justo JA, Rac H, Tucker K, Lashkova L, Dash S, Al-Hasan MN. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control. 2019 11; 47(11):1284-1289. PMID: 31221448.
      Citations:    
    24. Al-Hasan MN, Rac H. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections. Clin Microbiol Infect. 2020 Mar; 26(3):299-306. PMID: 31128289.
      Citations:    
    25. Al-Hasan MN, Justo JA. Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria? Clin Infect Dis. 2019 04 08; 68(8):1431. PMID: 30102340.
      Citations:    
    26. Ramsey EG, Royer J, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7. PMID: 30885805.
      Citations:    
    27. Battle SE, Augustine MR, Watson CM, Bookstaver PB, Kohn J, Owens WB, Baddour LM, Al-Hasan MN. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 2019 Aug; 47(4):571-578. PMID: 30737765.
      Citations:    
    28. Foster RA, Troficanto C, Bookstaver PB, Kohn J, Justo JA, Al-Hasan MN. Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals. Antibiotics (Basel). 2019 Feb 08; 8(1). PMID: 30744080.
      Citations:    
    29. Carlisle L, Justo JA, Al-Hasan MN. Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy. Antibiotics (Basel). 2018 Dec 01; 7(4). PMID: 30513755.
      Citations:    
    30. Al-Hasan MN, Albrecht H, Bookstaver PB, Kohn J, Justo JA. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979. PMID: 29365087.
      Citations:    
    31. Al-Jaghbeer MJ, Justo JA, Owens W, Kohn J, Bookstaver PB, Hucks J, Al-Hasan MN. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494. PMID: 29752649.
      Citations:    
    32. Al-Hasan MN, Nelson AN, Justo JA, Albrecht H, Kohn J, Brandon Bookstaver P. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284. PMID: 29417465.
      Citations:    
    33. Al-Hasan MN, Acker EC, Kohn JE, Bookstaver PB, Justo JA. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50. PMID: 29105102.
      Citations:    
    34. Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492. PMID: 28919195.
      Citations:    
    35. Sartelli M, Labricciosa FM, Barbadoro P, Pagani L, Ansaloni L, Brink AJ, Carlet J, Khanna A, Chichom-Mefire A, Coccolini F, Di Saverio S, May AK, Viale P, Watkins RR, Scudeller L, Abbo LM, Abu-Zidan FM, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Alis H, Alves C, Araujo da Silva AR, Augustin G, Bala M, Barie PS, Beltrán MA, Bhangu A, Bouchra B, Brecher SM, Caínzos MA, Camacho-Ortiz A, Catani M, Chandy SJ, Jusoh AC, Cherry-Bukowiec JR, Chiara O, Colak E, Cornely OA, Cui Y, Demetrashvili Z, De Simone B, De Waele JJ, Dhingra S, Di Marzo F, Dogjani A, Dorj G, Dortet L, Duane TM, Elmangory MM, Enani MA, Ferrada P, Esteban Foianini J, Gachabayov M, Gandhi C, Ghnnam WM, Giamarellou H, Gkiokas G, Gomi H, Goranovic T, Griffiths EA, Guerra Gronerth RI, Haidamus Monteiro JC, Hardcastle TC, Hecker A, Hodonou AM, Ioannidis O, Isik A, Iskandar KA, Kafil HS, Kanj SS, Kaplan LJ, Kapoor G, Karamarkovic AR, Kenig J, Kerschaever I, Khamis F, Khokha V, Kiguba R, Kim HB, Ko WC, Koike K, Kozlovska I, Kumar A, Lagunes L, Latifi R, Lee JG, Lee YR, Leppäniemi A, Li Y, Liang SY, Lowman W, Machain GM, Maegele M, Major P, Malama S, Manzano-Nunez R, Marinis A, Martinez Casas I, Marwah S, Maseda E, McFarlane ME, Memish Z, Mertz D, Mesina C, Mishra SK, Moore EE, Munyika A, Mylonakis E, Napolitano L, Negoi I, Nestorovic MD, Nicolau DP, Omari AH, Ordonez CA, Paiva JA, Pant ND, Parreira JG, Pedziwiatr M, Pereira BM, Ponce-de-Leon A, Poulakou G, Preller J, Pulcini C, Pupelis G, Quiodettis M, Rawson TM, Reis T, Rems M, Rizoli S, Roberts J, Pereira NR, Rodríguez-Baño J, Sakakushev B, Sanders J, Santos N, Sato N, Sawyer RG, Scarpelini S, Scoccia L, Shafiq N, Shelat V, Sifri CD, Siribumrungwong B, Søreide K, Soto R, de Souza HP, Talving P, Trung NT, Tessier JM, Tumbarello M, Ulrych J, Uranues S, Van Goor H, Vereczkei A, Wagenlehner F, Xiao Y, Yuan KC, Wechsler-Fördös A, Zahar JR, Zakrison TL, Zuckerbraun B, Zuidema WP, Catena F. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship-results from an international cross-sectional survey. World J Emerg Surg. 2017; 12:34. PMID: 28775763.
      Citations:    
    36. Nimmich EB, Bookstaver PB, Kohn J, Justo JA, Hammer KL, Albrecht H, Al-Hasan MN. Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence. Hosp Pharm. 2017 Nov; 52(10):691-697. PMID: 29276241.
      Citations:    
    37. Nelson AN, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620. PMID: 28478600.
      Citations:    
    38. Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5). PMID: 28193655.
      Citations:    
    39. Augustine MR, Testerman TL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Clinical Risk Score for Prediction of Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272. PMID: 27989244.
      Citations:    
    40. Edun B, Shah A, Durkin M, Whitmire M, Williams SP, Albrecht H, Al-Hasan M, Weissman S. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia. Infect Dis (Lond). 2017 May; 49(5):341-346. PMID: 27911152.
      Citations:    
    41. Battle SE, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304. PMID: 27986899.
      Citations:    
    42. Hammer KL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Differential effect of prior ß-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91. PMID: 27810318.
      Citations:    
    43. Kutob LF, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503. PMID: 27590704.
      Citations:    
    44. Hammer KL, Stoessel A, Justo JA, Bookstaver PB, Kohn J, Derrick CB, Albrecht H, Al-Hasan MN. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616. PMID: 27499192.
      Citations:    
    45. Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016; 11:33. PMID: 27429642.
      Citations:    
    46. Ereshefsky BJ, Al-Hasan MN, Gokun Y, Martin CA. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. J Chemother. 2017 Feb; 29(1):30-37. PMID: 27376664.
      Citations:    
    47. Dan S, Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72. PMID: 26833166.
      Citations:    
    48. Cain SE, Kohn J, Bookstaver PB, Albrecht H, Al-Hasan MN. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50. PMID: 25348527.
      Citations:    
    49. Watson CM, Al-Hasan MN. Bloodstream infections and central line-associated bloodstream infections. Surg Clin North Am. 2014 Dec; 94(6):1233-44. PMID: 25440121.
      Citations:    
    50. Bang DW, Yang HJ, Ryoo E, Al-Hasan MN, Lahr B, Baddour LM, Yawn BP, Juhn YJ. Asthma and risk of non-respiratory tract infection: a population-based case-control study. BMJ Open. 2013 Oct 03; 3(10):e003857. PMID: 24091424.
      Citations:    
    51. Krishnamohan P, Schaninger T, Baddour LM, Al-Hasan MN. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscesses. Am J Med Sci. 2013 Oct; 346(4):341-4. PMID: 23689049.
      Citations:    
    52. Myint T, Al-Hasan MN, Ribes JA, Murphy BS, Greenberg RN. Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009. J Int Assoc Provid AIDS Care. 2014 Mar-Apr; 13(2):100-5. PMID: 24029651.
      Citations:    
    53. Al-Hasan MN, Razonable RR, Kremers WK, Baddour LM. Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10. PMID: 21494179.
      Citations:    
    54. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011 May; 66(5):1156-60. PMID: 21393128.
      Citations:    
    55. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect. 2010 Jul; 61(1):28-33. PMID: 20378069.
      Citations:    
    56. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010 Feb; 85(2):139-44. PMID: 20118389.
      Citations:    
    57. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010 Apr; 60(4):278-85. PMID: 20114061.
      Citations:    
    58. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother. 2009 Jul; 64(1):169-74. PMID: 19435736.
      Citations:    
    59. Al-Hasan MN, Wilson JW, Lahr BD, Thomsen KM, Eckel-Passow JE, Vetter EA, Tleyjeh IM, Baddour LM. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 2009 Apr; 53(4):1386-94. PMID: 19164144.
      Citations:    
    60. Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med. 2008 Aug; 121(8):702-8. PMID: 18691484.
      Citations:    
    61. Al-Hasan MN, McCormick M, Ribes JA. Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007 Oct; 128(4):622-7. PMID: 17875514.
      Citations:    
    Al-Hasan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (149)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _